287 related articles for article (PubMed ID: 15642762)
21. Vascular remodeling in mice lacking the cytoplasmic domain of tissue factor.
Ott I; Michaelis C; Schuermann M; Steppich B; Seitz I; Dewerchin M; Zohlnhofer D; Wessely R; Rudelius M; Schömig A; Carmeliet P
Circ Res; 2005 Aug; 97(3):293-8. PubMed ID: 16020755
[TBL] [Abstract][Full Text] [Related]
22. c-Src-p38 mitogen-activated protein kinase signaling is required for Akt activation in response to ionizing radiation.
Kim MJ; Byun JY; Yun CH; Park IC; Lee KH; Lee SJ
Mol Cancer Res; 2008 Dec; 6(12):1872-80. PubMed ID: 19074832
[TBL] [Abstract][Full Text] [Related]
23. Inhibitors of factor VIIa affect the interface between the protease domain and tissue factor.
Carlsson K; Persson E; Carlsson U; Svensson M
Biochem Biophys Res Commun; 2006 Oct; 349(3):1111-6. PubMed ID: 16970919
[TBL] [Abstract][Full Text] [Related]
24. Hyaluronan-CD44 interaction stimulates Rac1 signaling and PKN gamma kinase activation leading to cytoskeleton function and cell migration in astrocytes.
Bourguignon LY; Gilad E; Peyrollier K; Brightman A; Swanson RA
J Neurochem; 2007 May; 101(4):1002-17. PubMed ID: 17403031
[TBL] [Abstract][Full Text] [Related]
25. Factor VIIa induces tissue factor-dependent up-regulation of interleukin-8 in a human keratinocyte line.
Wang X; Gjernes E; Prydz H
J Biol Chem; 2002 Jun; 277(26):23620-6. PubMed ID: 11973337
[TBL] [Abstract][Full Text] [Related]
26. Rac upregulates tissue inhibitor of metalloproteinase-1 expression by redox-dependent activation of extracellular signal-regulated kinase signaling.
Engers R; Springer E; Kehren V; Simic T; Young DA; Beier J; Klotz LO; Clark IM; Sies H; Gabbert HE
FEBS J; 2006 Oct; 273(20):4754-69. PubMed ID: 16984397
[TBL] [Abstract][Full Text] [Related]
27. Oncogenic K-Ras down-regulates Rac1 and RhoA activity and enhances migration and invasion of pancreatic carcinoma cells through activation of p38.
Dreissigacker U; Mueller MS; Unger M; Siegert P; Genze F; Gierschik P; Giehl K
Cell Signal; 2006 Aug; 18(8):1156-68. PubMed ID: 16257181
[TBL] [Abstract][Full Text] [Related]
28. Phosphatase-mediated crosstalk control of ERK and p38 MAPK signaling in corneal epithelial cells.
Wang Z; Yang H; Tachado SD; Capó-Aponte JE; Bildin VN; Koziel H; Reinach PS
Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5267-75. PubMed ID: 17122112
[TBL] [Abstract][Full Text] [Related]
29. Tissue factor/activated factor VIIa induces matrix metalloproteinase-7 expression through activation of c-Fos via ERK1/2 and p38 MAPK signaling pathways in human colon cancer cell.
Jia ZC; Wan YL; Tang JQ; Dai Y; Liu YC; Wang X; Zhu J
Int J Colorectal Dis; 2012 Apr; 27(4):437-45. PubMed ID: 22076613
[TBL] [Abstract][Full Text] [Related]
30. Muscle costameric protein, Chisel/Smpx, associates with focal adhesion complexes and modulates cell spreading in vitro via a Rac1/p38 pathway.
Schindeler A; Lavulo L; Harvey RP
Exp Cell Res; 2005 Jul; 307(2):367-80. PubMed ID: 15893749
[TBL] [Abstract][Full Text] [Related]
31. Epidermal growth factor stimulates Rac activation through Src and phosphatidylinositol 3-kinase to promote colonic epithelial cell migration.
Dise RS; Frey MR; Whitehead RH; Polk DB
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G276-85. PubMed ID: 17991704
[TBL] [Abstract][Full Text] [Related]
32. Activation of cancer cell migration and invasion by ectopic synthesis of coagulation factor VII.
Koizume S; Jin MS; Miyagi E; Hirahara F; Nakamura Y; Piao JH; Asai A; Yoshida A; Tsuchiya E; Ruf W; Miyagi Y
Cancer Res; 2006 Oct; 66(19):9453-60. PubMed ID: 17018600
[TBL] [Abstract][Full Text] [Related]
33. c-Met activation in medulloblastoma induces tissue factor expression and activity: effects on cell migration.
Provençal M; Labbé D; Veitch R; Boivin D; Rivard GE; Sartelet H; Robitaille Y; Gingras D; Béliveau R
Carcinogenesis; 2009 Jul; 30(7):1089-96. PubMed ID: 19359592
[TBL] [Abstract][Full Text] [Related]
34. Prevention of beta strand movement into a zymogen-like position does not confer higher activity to coagulation factor VIIa.
Olsen OH; Nielsen PF; Persson E
Biochemistry; 2004 Nov; 43(44):14096-103. PubMed ID: 15518559
[TBL] [Abstract][Full Text] [Related]
35. Transition state analysis of the complex between coagulation factor VIIa and tissue factor: suggesting a sequential domain-binding pathway.
Osterlund M; Persson E; Svensson M; Carlsson U; Freskgård PO
Biochem Biophys Res Commun; 2005 Feb; 327(3):789-93. PubMed ID: 15649415
[TBL] [Abstract][Full Text] [Related]
36. Selective attenuation of the extrinsic limb of the tissue factor-driven coagulation protease cascade by occupancy of a novel peptidyl docking site on tissue factor.
Huang H; Norledge BV; Liu C; Olson AJ; Edgington TS
Biochemistry; 2003 Sep; 42(36):10619-26. PubMed ID: 12962485
[TBL] [Abstract][Full Text] [Related]
37. Simvastatin induces apoptosis in human breast cancer cells in a NFkappaB-dependent manner and abolishes the anti-apoptotic signaling of TF/FVIIa and TF/FVIIa/FXa.
Aberg M; Wickström M; Siegbahn A
Thromb Res; 2008; 122(2):191-202. PubMed ID: 18031796
[TBL] [Abstract][Full Text] [Related]
38. Factor VIIa-induced p44/42 mitogen-activated protein kinase activation requires the proteolytic activity of factor VIIa and is independent of the tissue factor cytoplasmic domain.
Sørensen BB; Freskgård PO; Nielsen LS; Rao LV; Ezban M; Petersen LC
J Biol Chem; 1999 Jul; 274(30):21349-54. PubMed ID: 10409695
[TBL] [Abstract][Full Text] [Related]
39. Maspin controls mammary tumor cell migration through inhibiting Rac1 and Cdc42, but not the RhoA GTPase.
Shi HY; Stafford LJ; Liu Z; Liu M; Zhang M
Cell Motil Cytoskeleton; 2007 May; 64(5):338-46. PubMed ID: 17301947
[TBL] [Abstract][Full Text] [Related]
40. The interaction of activated factor VII with tissue factor: insight into the mechanism of cofactor-mediated activation of activated factor VII.
Ruf W
Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S73-8. PubMed ID: 9819032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
